General Information


DRACP ID  DRACP03681

Peptide Name  

Sequence  PRPRPRP

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C12

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C38H66N16O8

Absent amino acids  ACDEFGHIKLMNQSTVWY

Common amino acids  P

Mass  98222

Pl  12.8

Basic residues  3

Acidic residues  0

Hydrophobic residues  0

Net charge  3

Boman Index  -4476

Hydrophobicity  -284.29

Aliphatic Index  0

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29437631

Title  Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11101

DRACP is developed by Dr.Zheng's team.